// App-Quantinova.ai

4808 : Myeloproliferative Neoplasm with BCR-JAK2 Fusion Gene As the Result of t(9;22)(p24,11.2) in a Brazilian Patient

Researchers

Presenter

  • Marcelo Bellesso

Principal Investigators

  • Rodrigo Santucci

  • Renata Campos Elias

  • Veronica Ramos Oliveira

  • Renato Centrone

  • Adelson Alves

Medical Centers

  • Hemomed, Sao Paulo, Brazil

Locations

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Acute lymphoblastic leukemia

  • Myeloid neoplasms

  • Chronic Myelogenous Leukemia

  • Acute myelocytic leukemia

  • Polycythaemia vera

  • PDGFRA rearrangement

Biomarkers

  • Breakpoint Cluster Region

  • Platelet Derived Growth Factor Receptor Alpha

  • Fibroblast growth factor receptor 1

  • Janus kinase

Drug/Treatment

  • Mitoxantrone

  • Hydroxyurea

  • Hydroxycarbamide

  • Cytarabine liposomal

  • Interferon

  • dasatinib

  • Imatinib

  • IkT001

  • L-Tyrosine

  • Allopurinol

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim